Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,300
Closed -$4.87M 1265
2021
Q3
$4.87M Sell
7,300
-1,700
-19% -$1.17M 0.01% 688
2021
Q2
$6.11M Buy
+9,000
New +$5.84M 0.02% 653
2020
Q3
Sell
-2,800
Closed -$697K 1342
2020
Q2
$697K Buy
2,800
+200
+8% +$36.2K ﹤0.01% 1013
2020
Q1
$261K Buy
+2,600
New +$485K ﹤0.01% 1071
2018
Q4
Sell
-2,200
Closed -$288K 1361
2018
Q3
$288K Buy
+2,200
New +$309K ﹤0.01% 1237
2016
Q1
Sell
-185,000
Closed -$14.7M 1395
2015
Q4
$14.7M Sell
185,000
-5,000
-3% -$464K 0.06% 288
2015
Q3
$17.7M Sell
190,000
-12,000
-6% -$1.18M 0.07% 263
2015
Q2
$19.7M Buy
202,000
+29,000
+17% +$2.67M 0.08% 255
2015
Q1
$17.2M Sell
173,000
-19,500
-10% -$1.77M 0.07% 288
2014
Q4
$18.5M Buy
192,500
+27,500
+17% +$2.3M 0.07% 275
2014
Q3
$13.1M Buy
165,000
+84,800
+106% +$7.09M 0.06% 323
2014
Q2
$7.46M Buy
+80,200
New +$5.61M 0.03% 456

Other funds holding RH

Axa's RH Position: Q4 2021 in Review

Axa sold out of RH (RH) in Q4 2021, closing a stake of 7,300 shares — an estimated $4.87M sold.

Axa first reported a position in RH in Q2 2014 and held it in 12 quarters. The position peaked at $19.7M in Q2 2015. 481 funds tracked by Wall St. Rank hold RH as of Q4 2021.

  • Axa reported no remaining RH position as of Q4 2021 after selling out during the quarter.
  • Axa sold 7,300 RH shares in Q4 2021, an estimated $4.87M.
  • Axa first reported a position in RH in Q2 2014 and held it in 12 quarters.
  • Axa's RH position peaked at $19.7M in Q2 2015.
  • 481 funds tracked by Wall St. Rank held RH as of Q4 2021.

Based on Axa's 13F filing for Q4 2021, filed 14 Feb 2022.